Peptide Therapy
Telehealth only. Medication pricing is separate.

PEPTIDE PRICING
TB-500
MOTS-c
Semax
Epitalon
Recovery Stack
BPC-157 + TB-500
Patient prices are separate from the consultation fee and are not a guarantee of treatment or a prescription.
A Careful Conversation About Peptides
A clinician will review your health history, current medications, and individual needs, then discuss potential risks, uncertainties, and alternatives before any treatment decision is made.
Telehealth Only
Video visit from home. No home visit, service address, or travel fee.
Individual Evaluation
Your clinician reviews your health history and individual needs before making any treatment decision.
Clinical Decision
A consultation does not guarantee a prescription.
Why We Use a 503A Compounding Pharmacy
When a clinician determines that a peptide prescription may be appropriate, DRT works with a state-licensed 503A compounding pharmacy. Under 503A, a medication is compounded for an identified patient after the pharmacy receives a valid prescription.
For peptides covered by HHS’s interim policy, the policy describes ingredient-source documentation, quality testing, and safety reporting. This pharmacy-based process provides pharmacist oversight and documentation that may not be available from unverified sellers outside the licensed pharmacy system.
Compounded medications are not FDA-approved. FDA has not reviewed them for safety, effectiveness, or quality. A 503A prescription does not guarantee that a medication is appropriate for every patient or that it will be prescribed.


